To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Select Committee
Dr James Robertson
 OLG0020 - The Office for Local Government

Written Evidence Apr. 18 2024

Inquiry: The Office for Local Government
Inquiry Status: Closed
Committee: Levelling Up, Housing and Communities Committee (Department: Department for Levelling Up, Housing & Communities)

Found: In the medical context, research covers a cohort of known positives, eg having had a positive cancer

Written Question
Prostate Cancer: Ethnic Groups
Wednesday 17th April 2024

Asked by: Lord Bishop of St Albans (Bishops - Bishops)

Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have to prioritise research into variation of the prevalence of prostate cancer among different ethnic groups.

Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department welcomes the recently announced TRANSFORM trial which aims to save thousands of men each year by finding the best way to screen for prostate cancer across all ethnic groups. It will be spread across the United Kingdom, although final decisions on specific locations are yet to be taken. Men will be invited to participate via their general practices. This study, led by Prostate Cancer UK and supported by the Government among others, will also aim to address some of the inequalities that exist in prostate cancer diagnosis today by ensuring that one in ten of the trial participants will be black men, who are three times overrepresented compared to the population of men aged between 45 and 75 years old as based on 2021 census data.

More broadly, the National Institute for Health and Care Research (NIHR) funds research in response to proposals received from scientists and commissioned calls rather than allocating funding to specific disease areas. It welcomes funding applications for research into any aspect of human health, including prostate cancer. Applications are subject to peer review and judged in open competition, with awards being made based on the importance of the topic to patients and health and care services, value for money and scientific quality.

In addition, to raise awareness of prostate cancer in this group, Leicester’s Centre for BME Health has developed a toolkit in partnership with the NIHR with guidance on how to start conversations about prostate cancer and overcome barriers to diagnosis.

Departmental Publication (Transparency)
Home Office

Apr. 12 2024

Source Page: Non-technical summaries granted in 2024
Document: Non-technical summaries: projects granted in 2024, January to March (PDF)

Found: Modelling the Prostate Cancer Genome 125 16.

Scottish Parliament Written Question
S6W-26391
Friday 5th April 2024

Asked by: Swinney, John (Scottish National Party - Perthshire North)

Question

To ask the Scottish Government whether consideration is being given, as part of the review of the Scottish Referral Guidelines for Suspected Cancer, to risk factors such as family history and ethnicity in improving the early detection of prostate cancer.

Answered by Gray, Neil - Cabinet Secretary for NHS Recovery, Health and Social Care

A wealth of evidence is being collated and analysed as part of the 2024 Clinical Review of the Scottish Referral Guidelines for Suspected Cancer, including from key partners Cancer Research UK and Healthcare Improvement Scotland. All factors that are relevant in the context of symptoms suspicious of cancer based on available evidence, that could support primary care decision-making, will be considered in the Guideline review. The prostate peer review session (PRS), as part of the Review, is scheduled for May 2024.

Non-Departmental Publication (Guidance and Regulation)
Medicines and Healthcare products Regulatory Agency

Apr. 04 2024

Source Page: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines
Document: Q3D(R2) – Guideline for Elemental Impurities (PDF)

Found: ICH Q3D(R2) Guideline 16 IARC: International Agency for Research on Cancer.

Departmental Publication (Transparency)
HM Treasury

Mar. 21 2024

Source Page: HMT ministers' meetings, hospitality, gifts and overseas travel: 1 October to 31 December 2023
Document: (webpage)

Found: Jeremy Hunt 17/10/2023 Soho House; Prostate Cancer Research To discuss the Daily Mail campaign ‘End Needless

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 1 (PDF)

Found: cancer (5), malignant melano ma (3), brain cancer (2), thyro id cancer (2), non -Hodgkin’s lympho ma

Non-Departmental Publication (Transparency)
Medicines and Healthcare products Regulatory Agency

Mar. 14 2024

Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/774 - attachment 2 (PDF)

Found: The case is confounded by metastatic prostate cancer.

Commons Chamber
Business of the House - Thu 14 Mar 2024
Leader of the House

Mentions:
1: Richard Burgon (Lab - Leeds East) I want to raise with the Leader of the House a shocking statistic: research shows that more than 300,000 - Speech Link
2: Tom Hunt (Con - Ipswich) However, last September, he took over as the chief executive officer of Cancer Support Suffolk, and has - Speech Link
3: Penny Mordaunt (Con - Portsmouth North) We have had some good news on cancer outcomes today. - Speech Link

Scottish Government Publication (Factsheet)

Mar. 13 2024

Source Page: Scottish Health Survey and health record data
Document: Scottish Health Survey and health record data variables: March 2024 (Excel)

Found: of registrations for cancer of the large bowelSMR06bowelincDate of first incidence of cancer of the